MUMBAI, INDIA: Clariant said that its new greenfield production facility in Cuddalore, Tamil Nadu, India is scheduled as planned and is likely to begin production of dessicant canisters by the second semester of 2017. This plant will be an important supplier to Clariant's global desiccant canister production.
Clariant's business line Healthcare Packaging had performed the groundbreaking ceremony of this plant in January 2016. This facility will produce desiccant canisters, the primary desiccant platform for high-speed, high-volume packaging lines, often the case for generic drug manufacturers.
Additionally, Clariant is already measuring plans for expanded production, including plans to add high-capacity multi-lane production of its versatile Continu-Strip desiccant packets, which can be introduced with numerous types of standard dessicant insertion machinery.
Clariant's wide business footmark confirms quick delivery and competitive pricing, as well backup capacity to meet the BCP (Business Continuity Planning) requirements of global players in the pharmaceutical industry.
All products produced at the Cuddalore facility will meet US FDA and EU standards for use in pharmaceutical applications and will be USP biddable. The Cuddalore facility is equipped with an ISO Class 8 clean room and will implement GMPs and environmental controls with a path toward ISO 15378 certification.
"The new site will serve the Indian pharmaceutical industry with state-of-the-art desiccant products produced under the strictest quality and compliance standards, and within a secure, truly global manufacturing network," said Matthias Brommer, head - Clariant healthcare packaging.
"This facility and the other Healthcare Packaging facilities around the globe ensure available backup capacity to meet the BCP (Business Continuity Planning) requirements of our global customers," said Ketan Premani, head – healthcare packaging India.
© Worldofchemicals News